Numinus to Participate in Microdose Hosted Events: Psychedelic Capital and Wonderland: Miami Pharmaceutical Investing
Allergan, an AbbVie Company, to Present New Data on Investigational AGN-190584 for the Treatment of Presbyopia Pharmaceutical Investing
HealthTab Expands to British Columbia in Select Shoppers Drug Mart® Locations Pharmaceutical Investing
Gilead and Merck Initiate Phase 2 Study Evaluating an Oral Weekly Combination Regimen of Investigational Lenacapavir and Investigational Islatravir for HIV-1 Treatment in Virologically Suppressed Adults Pharmaceutical Investing
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS APPH, BMY, EAR, HYZN INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Universal Ibogaine Announces Engagement of Media and Investor Relations Advisors Pharmaceutical Investing
New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States Pharmaceutical Investing
Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx for Acute Myocarditis Pharmaceutical Investing
Salix Will Feature New Data At The American College Of Gastroenterology® 2021 Annual Scientific Meeting Pharmaceutical Investing
Bristol Myers Squibb Announces Earnings Call Time Change; Third Quarter 2021 Earnings Call to Occur on October 27, 2021 at 10 a.m. Pharmaceutical Investing
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis Pharmaceutical Investing
